Fetal anomaly · pregnant women with pre‐existing diabetes
1 finding from 1 review
Fetal anomaly · pregnant women with pre‐existing diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal anomaly (major) · pregnant women with pre‐existing diabetes
It is very uncertain whether insulin Detemir + prandial insulin Aspart changes fetal anomaly (major) compared with NPH insulin + prandial insulin Aspart (Different insulin types… (very low certainty).
1 finding from 1 review
Fetal anomaly · pregnant women with pre‐existing diabetes
It is very uncertain whether lispro changes fetal anomaly compared with regular insulin (Different insulin types within similar insulin… (very low certainty).
1 finding from 1 review
Perinatal (fetal and neonatal death) and later infant mortality · women with gestational diabetes mellitus
Lifestyle showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with control ‐ Neonatal and later outcomes (low certainty).
1 finding from 1 review
Perinatal (fetal and neonatal death) and later infant mortality · Infants of women diagnosed with gestational diabetes
Insulin showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with anti‐diabetic agent (low certainty).
1 finding from 1 review
Total fetal loss (including miscarriages or combined miscarriages and stillbirths) · pregnant women
Vitamin C and vitamin E showed no clear difference in total fetal loss compared with placebo (high certainty).
1 finding from 1 review
Total fetal loss (including miscarriages or combined miscarriages and stillbirths) · pregnant women
Vitamin A plus iron plus folate showed no clear difference in total fetal loss (including miscarriages or combined miscarriages… compared with iron plus folate (low certainty).
1 finding from 1 review
Total fetal loss (including miscarriages or combined miscarriages and stillbirths) · pregnant women
Multivitamin plus iron plus folate showed no clear difference in total fetal loss (including miscarriages or combined miscarriages… compared with iron plus folate (high certainty).
1 finding from 1 review
Adverse fetal outcomes · women with idiopathic hyperprolactinemia and recurrent miscarriage history
1 finding from 1 review
Severity, reduction or cessation in nausea/vomiting 2. Quality of life outcomes 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity, reduction or cessation in nausea/vomiting 2.Days of hospital admission 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal bradycardia (primary) · patients with breech presentation
Regional analgesia (with tocolysis) showed no clear difference in fetal bradycardia (primary) compared with no intervention of regional analgesia (with or without tocolysis) (low certainty).
1 finding from 1 review
Fetal bradycardia (primary) · patients with breech presentation
It is very uncertain whether beta stimulant changes fetal bradycardia (primary) compared with placebo (very low certainty).
1 finding from 1 review
Preterm prelabour rupture of membranes · pregnant women receiving vitamin E supplementation or control, living in areas where there is either inadequate dietary intake of vitamin…
Any vitamin E supplementation showed no clear difference in prelabour rupture of fetal membranes ‐ preterm compared with placebo, no placebo or other supplements (low certainty).
1 finding from 1 review
Perinatal mortality (stillbirth ‐ death of fetus prior to birth; neonatal death ‐ death within the first 28 days of birth; or infant death ‐ death after the first 28 days) · pregnant women with a term suspected compromised baby
1 finding from 1 review
Intervention not reported
Fetal, neonatal and infant death · Women in preterm labour
It is very uncertain whether the intervention changes fetal, neonatal and infant death (very low certainty).
1 finding from 1 review